We are live on ! Find out more
HIM

HGC Investment Management Portfolio holdings

AUM $507M Turnover 38.25%
1-Year Est. Return 6.15%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+6.15%
3 Year Est. Return
+33.24%
5 Year Est. Return
+43.48%
10 Year Est. Return
–
AUM
$507M
AUM Growth
+$55.2M
Cap. Flow
+$50.6M
Cap. Flow %
9.99%
Top 10 Hldgs %
23.74%
Holding
217
New
49
Increased
7
Reduced
7
Closed
34
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.3 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GIXXU icon
101
GigCapital9 Corp Units
GIXXU
$1.02M 0.2%
100,000
– –
2026 Q1
1 quarter
PTACU icon
102
Patriot Acquisition Corp Units
PTACU
$999K 0.2%
+100,000
New +$998K
2026 Q2
0 quarters
MLAA icon
103
Mountain Lake Acquisition Corp II
MLAA
$993K 0.2%
+100,000
New +$997K
2026 Q2
0 quarters
WBD icon
104
DELISTED
Warner Bros
WBD
$667K 0.13%
+25,000
New +$676K
2026 Q2
0 quarters
AACBR
105
DELISTED
Artius II Acquisition Inc Rights
AACBR
$315K 0.06%
1,500,000
– –
2025 Q3
3 quarters
SDHIR icon
106
Siddhi Acquisition Corp Right
SDHIR
$303K 0.06%
1,250,000
– –
2025 Q3
3 quarters
APGE icon
107
DELISTED
Apogee Therapeutics
APGE
$301K 0.06%
+2,268
New +$204K
2026 Q2
0 quarters
KRAQ icon
108
KRAKacquisition Corp
KRAQ
$432M
$278K 0.05%
+27,776
New +$276K
2026 Q2
0 quarters
JACS icon
109
Jackson Acquisition Co II
JACS
$320M
$266K 0.05%
25,000
– –
2025 Q2
4 quarters
DSACU icon
110
Daedalus Special Acquisition Corp Unit
DSACU
$260K 0.05%
25,000
– –
2025 Q4
2 quarters
IPFX icon
111
Inflection Point Acquisition Corp VI
IPFX
$338M
$259K 0.05%
+25,000
New +$259K
2026 Q2
0 quarters
IPCXR
112
DELISTED
Inflection Point Acquisition Corp III Rights
IPCXR
$216K 0.04%
479,341
+14,341
+3% +$5.58K
2025 Q3
3 quarters
PAII.WS icon
113
Pyrophyte Acquisition Corp II Warrants
PAII.WS
$213K 0.04%
425,000
– –
2025 Q4
2 quarters
FERAR icon
114
Fifth Era Acquisition Corp I Rights
FERAR
$211K 0.04%
+640,660
New +$187K
2026 Q2
0 quarters
JACS.RT icon
115
Jackson Acquisition Co II Rights
JACS.RT
$200K 0.04%
1,425,700
– –
2025 Q2
4 quarters
GSRFR icon
116
GSR IV Acquisition Corp Rights
GSRFR
$181K 0.04%
75,000
– –
2025 Q4
2 quarters
TECH icon
117
Bio-Techne
TECH
$11.4B
$177K 0.03%
+2,500
New +$135K
2026 Q2
0 quarters
PMTRW icon
118
Perimeter Acquisition Corp I Warrant
PMTRW
$6.52M
$175K 0.03%
194,200
– –
2025 Q4
2 quarters
HCMAW icon
119
HCM III Acquisition Corp Warrants
HCMAW
$6.22M
$173K 0.03%
266,666
– –
2025 Q3
3 quarters
PEN icon
120
Penumbra
PEN
$12.7B
$169K 0.03%
534
– –
2026 Q1
1 quarter
COLAR
121
DELISTED
Columbus Acquisition Corp Rights
COLAR
$165K 0.03%
300,000
– –
2025 Q4
2 quarters
TACHW icon
122
Titan Acquisition Corp Warrants
TACHW
$6.2M
$143K 0.03%
200,000
+100,000
+100% +$47.8K
2025 Q4
2 quarters
TACOW icon
123
Berto Acquisition Corp Warrant
TACOW
$12.2M
$125K 0.02%
175,000
– –
2025 Q2
4 quarters
JENA.RT icon
124
Jena Acquisition Corp II Rights
JENA.RT
$119K 0.02%
700,000
– –
2025 Q4
2 quarters
AEXA icon
125
American Exceptionalism Acquisition Corp
AEXA
$534M
$118K 0.02%
10,000
– –
2025 Q3
3 quarters

Similar funds

HGC Investment Management's Q2 2026 Portfolio in Review

As of Q2 2026, HGC Investment Management held 217 positions worth $507M, up 12% from $451M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

HGC Investment Management deployed $50.6M of net new capital in Q2 2026, opening 49 new positions and adding to 7 existing holdings. Its largest new stake was CH4 Natural Solutions Corp Units: 1,250,000 shares worth $12.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 61% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Drugs Made In America Acquisition II Corp, an estimated $10.8M trimmed.

  • HGC Investment Management's largest Q2 2026 buy was CH4 Natural Solutions Corp Units: 1,250,000 shares worth $12.5M.
  • HGC Investment Management added most to OneIM Acquisition Corp in Q2 2026, an estimated $2M increase.
  • HGC Investment Management's biggest Q2 2026 reduction was Drugs Made In America Acquisition II Corp, cutting an estimated $10.8M.
  • HGC Investment Management fully exited Fifth Era Acquisition Corp I Units in Q2 2026, selling an estimated $12.1M.
  • HGC Investment Management's ten largest holdings make up 24% of its $507M portfolio in Q2 2026.
  • HGC Investment Management opened 49 new positions and closed 34 in Q2 2026.
  • HGC Investment Management's portfolio value rose 12% quarter-over-quarter to $507M.

Based on HGC Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.